NA/CA EXCHANGE, BRAIN AGING, ALZHEIMER'S DISEASE
NA/CA EXCHANGE, BRAIN AGING, ALZHEIMER'S DISEASE
批准号:
3417290
负责人:
ROBERT A COLVIN
金额:
$14.16万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-09-30 至 1994-09-29
关键词:
Alzheimer's disease SDS polyacrylamide gel electrophoresis aging amyloid proteins calcium flux calcium metabolism cell death central nervous system chemical kinetics disease /disorder model immunocytochemistry laboratory rat membrane permeability monoclonal antibody neural degeneration potassium western blottings
中文摘要
根据RFA NS/AG-91-03要求提供经费以研究
英文摘要
Funding is requested under RFA NS/AG-91-03 to study the mechanisms of
neuronal cell death in normal human aging and Alzheimer's disease. The
cognitive decline associated with aging and the human neurodegenerative
diseases (e.g. Alzheimer's disease, Parkinson's disease and Huntington's
disease) is most certainly caused by neuronal dysfunction, eventual cell
death, and loss of synapses (1). But, what are the causes of neural
degeneration and death? The "calcium hypothesis of brain aging" (2)
proposes that changes in the cellular mechanisms that act to modulate
the concentration of free intracellular calcium ([Cai]) within the
neuron contribute to the causative factors leading to neuronal
dysfunction and degeneration. A similar hypothesis has also been
proposed to explain the neurodegenerative processes occurring in
Alzheimer's disease (AD). The "calcium hypothesis of AD" proposes that
a loss of Cai homeostasis is the final common pathway to neuronal
degeneration. Unfortunately, very little is known about the effects of
human aging and AD on neuronal Ca2+ homeostatic processes. This
proposal describes a focused study of the properties of neuronal plasma
membrane Na+/Ca2+ countertransport in the aging rat brain, the aging
human central nervous system (CNS) and in AD. The specific aims of this
study are as follows:
1. Determine the effect of an animal model of aging, normal human aging
and AD on several important molecular and kinetic properties of neuronal
plasma membrane Na+/Ca2+ countertransport.
a. the Km and Vmax for Ca2+ activation of Ca2+ transport
b. the passive permeability of the plasma membrane to Ca2+
c. evidence for the presence of K+ sensitive and insensitive forms of
the Na+/Ca2+ exchanger in rat brain and the human central nervous (CNS)
d. the effect of lipophilic peptides (including betaA41-40, betaA425-35,
and substance P analogs) on the Na+/Ca2+ exchanger
e. molecular weight determination by SDS PAGE and western blot analysis
using monoclonal antibodies (MAB) raised to peptide sequences of the dog
heart exchanger
f. the cellular location of the exchanger depicted by
immunocytochemistry using the same MAB
2. Analyze the relationship between age of onset of AD and items
1.a-e above.
3. Using tissues from well documented familial AD, determine the effect
on Km and Vmax for Ca2+ activation of Ca2+ transport and western blot
analysis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
International Society for Zinc Biology Conference
-
批准号:8786277
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2014
-
负责人:ROBERT A COLVIN
-
依托单位:
Immunopathology Core
-
批准号:6782114
-
项目类别:
-
资助金额:$12.39万
-
财政年份:2003
-
负责人:ROBERT A COLVIN
-
依托单位:
Zinc transport and homeostasis in cortical neurons
-
批准号:6457155
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2002
-
负责人:ROBERT A COLVIN
-
依托单位:
ZINC TRANSPORT IN THE HUMAN BRAIN
-
批准号:6050804
-
项目类别:
-
资助金额:$7.2万
-
财政年份:1999
-
负责人:ROBERT A COLVIN
-
依托单位:
NA/CA EXCHANGE, BRAIN AGING, ALZHEIMER'S DISEASE
-
批准号:2268383
-
项目类别:
-
资助金额:$13.92万
-
财政年份:1991
-
负责人:ROBERT A COLVIN
-
依托单位:
NA/CA EXCHANGE, BRAIN AGING, ALZHEIMER'S DISEASE
-
批准号:3417291
-
项目类别:
-
资助金额:$13.38万
-
财政年份:1991
-
负责人:ROBERT A COLVIN
-
依托单位:
Immunopathology Core
-
批准号:7526045
-
项目类别:
-
资助金额:$12.76万
-
财政年份:--
-
负责人:ROBERT A COLVIN
-
依托单位:
Immunopathology Core
-
批准号:7526053
-
项目类别:
-
资助金额:$41.88万
-
财政年份:--
-
负责人:ROBERT A COLVIN
-
依托单位:
Immunopathology Core
-
批准号:7526057
-
项目类别:
-
资助金额:$52.11万
-
财政年份:--
-
负责人:ROBERT A COLVIN
-
依托单位:
Immunopathology Core
-
批准号:7526049
-
项目类别:
-
资助金额:$13.05万
-
财政年份:--
-
负责人:ROBERT A COLVIN
-
依托单位: